The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 02, 2025
Filed:
Nov. 30, 2018
Applicant:
Mary Kay Inc., Addison, TX (US);
Inventors:
Assignee:
MARY KAY INC., Addison, TX (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 8/70 (2006.01); A61K 8/06 (2006.01); A61K 8/11 (2006.01); A61K 8/20 (2006.01); A61K 8/34 (2006.01); A61K 8/37 (2006.01); A61K 8/41 (2006.01); A61K 8/42 (2006.01); A61K 8/43 (2006.01); A61K 8/60 (2006.01); A61K 8/64 (2006.01); A61K 8/73 (2006.01); A61K 8/9722 (2017.01); A61K 8/9789 (2017.01); A61Q 17/04 (2006.01); A61Q 19/00 (2006.01); A61Q 19/02 (2006.01); A61Q 19/08 (2006.01); A61Q 19/10 (2006.01);
U.S. Cl.
CPC ...
A61K 8/70 (2013.01); A61K 8/064 (2013.01); A61K 8/11 (2013.01); A61K 8/20 (2013.01); A61K 8/34 (2013.01); A61K 8/342 (2013.01); A61K 8/345 (2013.01); A61K 8/347 (2013.01); A61K 8/37 (2013.01); A61K 8/375 (2013.01); A61K 8/41 (2013.01); A61K 8/42 (2013.01); A61K 8/43 (2013.01); A61K 8/60 (2013.01); A61K 8/64 (2013.01); A61K 8/73 (2013.01); A61K 8/733 (2013.01); A61K 8/9722 (2017.08); A61K 8/9789 (2017.08); A61Q 17/04 (2013.01); A61Q 19/007 (2013.01); A61Q 19/008 (2013.01); A61Q 19/02 (2013.01); A61Q 19/08 (2013.01); A61Q 19/10 (2013.01); A61K 2800/522 (2013.01); A61K 2800/596 (2013.01); A61K 2800/70 (2013.01); A61K 2800/78 (2013.01); A61K 2800/782 (2013.01);
Abstract
Disclosed are compositions and methods for their use that can be used in cosmetic applications. The composition can include an effective amount of astem cells to reduce the activity of hyaluronidase in skin, an effective amount of tetradecyl aminobutyroylvalylamino butyric urea trifluoroacetate orleaf extract to promote the production of hyaluronic acid in skin, an effective amount of tripeptide-1 to promote the production of fibronectin and laminin in skin, and a dermatologically acceptable vehicle.